CCR9 Antagonists in the Treatment of Ulcerative Colitis.
about
Intestinal Dendritic Cells Are Altered in Number, Maturity and Chemotactic Ability in Fulminant Hepatic Failure.Letter: the therapeutic potential of targeting CCL25/CCR9 in colonic inflammatory bowel disease - reading between the lines.Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise
P2860
CCR9 Antagonists in the Treatment of Ulcerative Colitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CCR9 Antagonists in the Treatment of Ulcerative Colitis.
@ast
CCR9 Antagonists in the Treatment of Ulcerative Colitis.
@en
type
label
CCR9 Antagonists in the Treatment of Ulcerative Colitis.
@ast
CCR9 Antagonists in the Treatment of Ulcerative Colitis.
@en
prefLabel
CCR9 Antagonists in the Treatment of Ulcerative Colitis.
@ast
CCR9 Antagonists in the Treatment of Ulcerative Colitis.
@en
P2093
P2860
P356
P1476
CCR9 Antagonists in the Treatment of Ulcerative Colitis
@en
P2093
Jay P Powers
Juan C Jaen
Karen Ebsworth
Linda S Ertl
Matthew J Walters
Pirow Bekker
Robert D Berahovich
Sreenivas Punna
Thomas J Schall
Timothy J Sullivan
P2860
P304
P356
10.1155/2015/628340
P577
2015-09-20T00:00:00Z